Expert Hour: Biologics & Immune Therapy Workflows with Venkataraman Sriram

​Venkataraman Sriram, PhD ([email protected]) is an immunotherapy innovator with 18+ years of experience translating discovery science into clinical-stage therapeutics. His expertise spans preclinical pharmacology (in-vitro, in-vivo, ex-vivo), translational strategy, IND submissions, and strategic external partnerships. From building the research team at Pionyr Immunotherapeutics to leading programs at Gilead and Merck—including work connected to Keytruda—Sriram has helped shape modern tumor immunotherapy. He is a co-founder of Foundery Biosciences, which operated out of MBC BioLabs at 953 Indiana St., San Francisco.